MINNEAPOLIS, MN, Nov. 14, 2011 /PRNewswire/ - BioAmber Inc. has filed a
registration statement on Form S-1 with the Securities and Exchange
Commission for a proposed initial public offering of its common stock.
The number of shares to be offered in the proposed offering and the
price range for the offering have not yet been determined. The lead
book-running managers for the offering are Goldman, Sachs & Co. and
Credit Suisse Securities (USA) LLC. The additional book-running
manager is Barclays Capital. The co-managers are Stifel, Nicolaus &
Company, Incorporated and Pacific Crest Securities LLC.
When available, a copy of the preliminary prospectus relating to these
securities may be obtained from Goldman, Sachs & Co. at 200 West
Street, New York, New York 10004, Attn: Prospectus Department, by
calling 1-212-902-1171, or by emailing firstname.lastname@example.org, and from Credit Suisse Securities (USA) LLC, Attention: Prospectus
Department, One Madison Avenue, New York, New York, 10010, by calling
+1 (800) 221-1037, or by e-mailing email@example.com.
A registration statement relating to these securities has been filed
with the Securities and Exchange Commission but has not yet become
effective. These securities may not be sold, nor may offers to buy be
accepted, prior to the time the registration statement becomes
effective. This press release shall not constitute an offer to sell or
the solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which such an offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
About BioAmber Inc.
BioAmber is a next generation chemicals company. Its proprietary
technology platform combines industrial biotechnology, an innovative
purification process and chemical catalysis to convert renewable
feedstocks into chemicals for use in a wide variety of everyday
products including plastics, food additives and personal care products.
BioAmber produces bio-succinic acid in what it believes to be one of
the world's largest bio-based chemical manufacturing facilities. For
more information visit the company's web site at www.bio-amber.com or contact:
SOURCE BIOAMBER INC.